Search results for "Non diabetic"

showing 8 items of 8 documents

Comparison of total antioxidant capacity of saliva in women with gestational diabetes mellitus and non-diabetic pregnant women

2017

Background Pregnancy is considered a stressful event, results in higher levels of oxidative stress and considerable changes in physiological and metabolic functions such as gestational diabetes mellitus (GDM). Due to the cumulative effect of antioxidants and considering the controversies in this area, this study was undertaken to investigate the total antioxidant capacity (TAC) of saliva in pregnant women whit gestational diabetes in comparison to non-diabetic pregnant women. Material and methods In this cross-sectional study (2015-16), a total of 31 women with a diagnosis of GDM and 59 non-diabetic pregnant women were included in the diabetic and control groups, respectively. Salivary samp…

0301 basic medicinemedicine.medical_specialtySalivaPhysiologymedicine.disease_cause03 medical and health sciences0302 clinical medicineInternal medicineDiabetes mellitusMedicineGeneral DentistryCumulative effectPregnancyOral Medicine and Pathologybusiness.industryResearchmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Gestational diabetesAntioxidant capacity030104 developmental biologyEndocrinology030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASbusinessOxidative stressNon diabetic
researchProduct

Impact pronostique de l’HbA1c et de la glycémie plasmatique (Gp) à la phase aiguë d’un infarctus du myocarde sur la mortalité à un an chez des patien…

2020

International audience; Background: The usefulness of the combined assessment of HbA1c and plasma glucose (PG) in acute myocardial infarction (AMI) in non-diabetic patients remains unclear.Purpose: In a large observational study, we aimed to identify the prognostic values of these biomarkers regarding one-year all-cause mortality in non-diabetic patients after AMI.Methods: From the "obseRvatoire des Infarctus de Côte d'Or" (RICO) survey database, we included all consecutive non-diabetic patients with AMI (n=6617) from May 2001 to December 2016. Exclusion criteria were: admission known or unknown diabetes, in-hospital death. The primary endpoint was all-cause one-year mortality. The secondar…

Gynecologymedicine.medical_specialtyHbA1cbusiness.industryGlycemic stress[SDV]Life Sciences [q-bio]Non-diabetic030204 cardiovascular system & hematologyMyocardial infraction3. Good health[SDV] Life Sciences [q-bio]One year mortality03 medical and health sciencesOne-year mortality0302 clinical medicineMedicineCardiology and Cardiovascular MedicinebusinessNon diabetic
researchProduct

Time-course of insulin resistance during antiviral therapy in non-diabetic non-cirrhotic patients with genotype 1 HCV infection

2009

Insulin resistanceHepatologybusiness.industryTime courseImmunologyGenotypeGastroenterologymedicineAntiviral therapymedicine.diseasebusinessVirologyNon diabeticDigestive and Liver Disease
researchProduct

P4570Prognostic interest of HbA1c and plasma glucose assessment on one-year mortality in non-diabetic patients after acute myocardial infarction

2019

Abstract Background The usefulness of the combined assessment of HbA1c and plasma glucose (PG) in acute myocardial infarction (AMI) in nondiabetic patients remains unclear. Purpose In a large observational study, we aimed to identify the prognostic values of these biomarkers regarding one-year all-cause mortality in nondiabetic patients after AMI. Methods From the “obseRvatoire des Infarctus de Côte d'Or” (RICO) survey database, we included all consecutive nondiabetic patients with AMI (n=6617) from May 2001 to December 2016. Exclusion criteria were: admission known or unknown diabetes, in-hospital death. The primary endpoint was all-cause one-year mortality. The secondary endpoints were: M…

One year mortalityPlasma glucosemedicine.medical_specialtybusiness.industryInternal medicinemedicineCardiologyMyocardial infarctionCardiology and Cardiovascular Medicinemedicine.diseasebusinessNon diabeticEuropean Heart Journal
researchProduct

High performance liquid chromatography analysis of tear protein patterns in diabetic and non-diabetic dry-eye patients.

2001

To analyze and compare the high performance liquid chromatography (HPLC) runs of tear proteins from diabetic (DIDRY) and non-diabetic (DRY) dry-eye patients, and healthy subjects (CTRL). The patterns were analyzed using multivariate statistical methods.Tears (total 56 eyes: CTRL: n=16, DIDRY: n=21, and DRY: n=19) were analyzed by HPLC, using a size-exclusion column with an eluent of 0.5 M sodium phosphate buffer. The patients were primarily grouped according to the results of the basic secretory test (BST) in combination with subjective symptoms such as burning, foreign body sensations, tearing, and "dryness" of the eyes. Patients with BST valuesor = 10 mm/5 min plus two subjective symptoms…

medicine.medical_specialtyEye diseaseTear proteinsHigh-performance liquid chromatographyDiabetes Complications03 medical and health sciences0302 clinical medicineOphthalmologyDiabetes mellitusDiabetes MellitusMedicineHumansEye ProteinsChromatography High Pressure Liquidbusiness.industryHealthy subjectsGeneral Medicinemedicine.diseaseeye diseasesSurgeryOphthalmologyTearsMultivariate Analysis030221 ophthalmology & optometryChromatography GelTearsDry Eye Syndromessense organsbusiness030217 neurology & neurosurgeryNon diabeticEuropean journal of ophthalmology
researchProduct

Impact of admission hyperglycemia on one-year mortality in non-diabetic patients admitted for rescue PCI

2013

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentCardiogenic shockPercutaneous coronary interventionInfarctionmedicine.diseaseIntensive care unitlaw.inventionlawDiabetes mellitusEmergency medicineConventional PCIMedicineMyocardial infarctionMedical emergencyCardiology and Cardiovascular MedicinebusinessNon diabeticEuropean Heart Journal
researchProduct

0432: Impact of admission hyperglycemia on one-year mortality in non-diabetic patients admitted for rescue PCI: Data from the “Observatoire des infar…

2014

BackgroundRescue percutaneous coronary intervention (PCI) is associated with improved clinical outcomes for ST-segment myocardial infarction (STEMI) patients after failed fibrinolysis therapy. Hyperglycemia on admission has been shown to be a powerful predictor of mortality after acute myocardial infarction, particularly in non-diabetic patients. The aim of our study was to assess the predictive value of admission glucose levels on long-term mortality in patients with rescue PCI.Patients and MethodsFrom the “Observatoire des infarctus de Côte d’Or” (RICO) survey, 510 consecutive non-diabetic STEMI patients admitted to the intensive care unit for rescue PCI after failed fibrinolysis therapy …

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentPercutaneous coronary interventionmedicine.diseaseIntensive care unitSurgerylaw.inventionOne year mortalitysurgical procedures operativelawEmergency medicineConventional PCIFibrinolysismedicinecardiovascular diseasesMyocardial infarctionCardiology and Cardiovascular MedicinebusinessGlycemicNon diabeticArchives of Cardiovascular Diseases Supplements
researchProduct

Microalbuminuria and endothelial activation in treated and untreated diabetic and non-diabetic hypertensives

2004

medicine.medical_specialtymicroalbuminuriabiologybusiness.industryRenal functionendothelial activationmedicine.diseaseEndothelial activationEndocrinologyVon Willebrand factorDiabetes mellitusInternal medicineE-selectinInternal Medicinebiology.proteinmedicineadhesion moleculesMicroalbuminuriabusinessNon diabeticAmerican Journal of Hypertension
researchProduct